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Antimycin A and UHBDT inhibit the activity of the purified cytochrome bd complex from Azotobacter vinekmdii. Inhibition of activity is 
non-competitive and antimycin A binding induces a shift to the red in the spectrum of a b-type haem. No inhibitory effects were seen with myxothiazol. 
Steady-state xperiments indicate that the site of inhibition for antimycin A lies on the low-potential side of haem bU8. In the presence of antimycin 
A at concentrations ufficient o inhibit respiration, some direct electron transfer from ubiquinol-1 to haem bsg5 and haem d still occurs. The results 
are consistent with a branched electron transfer pathway from ubiquinol to the oxygen reduction site. 
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1. Introduction 
The cytochrome bd complex is one of two terminal 
oxidases of Azotobacter vinelandii [l] which are thought 
to play an essential role in aerotolerant nitrogen fixation 
[2]. The complex from A. vinelandii shows spectral, im- 
munological [3,4] and genetic [5] similarities to the E. coli 
bd oxidase. It comprises two subunits [6] and functions 
as a quinol oxidase with the quinol binding site, in the 
E. coli enzyme, located on a hydrophilic loop of subunit 
I at the periplasmic side of the bilayer [7,8]. Subunit I 
also contains the hexacoordinate haem b558 whilst the 
other two redox centres (haem b595 and haem d) appear 
to be located in subunit II [9], although ligation to both 
subunits cannot be excluded. 
The use of specific inhibitors has long been a produc- 
tive method for probing structure+function relationships 
in the active centres of redox proteins. Monoclonal anti- 
bodies have been used on the cytochrome bd complex of 
E. coli to localize the ubiquinol oxidation site to between 
the fifth and sixth putative membrane spanning segments 
of subunit I [8]. Trypsin digestion of the E. coli enzyme 
has been shown to cleave subunit I with a corresponding 
loss of ubiquinol oxidase activity while TMPD oxidase 
activity was unaffected [7]. Electron flow from ubiquinol 
to molecular oxygen in E. coli is reported to be inhibited 
by antimycin A [lo], and the oxygen reduction site itself 
has been probed using cyanide [l 11, CO [ 12-141 and 
nitrite [15,16]. Recently, interest has been raised in the 
mechanism of ubiquinol oxidation in the copper-con- 
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taining quinol oxidases by speculation about a Q-loop 
mechanism for electron and proton transfer in these en- 
zymes [17]. The bd oxidases are non-homologous in se- 
quence with the copper-containing oxidases but do share 
the common feature of a quinol oxidation site close to 
a hexacoordinate haem b. Antimycin A, myxothiazol 
and UHDBT are classical inhibitors of the Q-cycle in the 
mitochondrial bc, complex [18] and we report here their 
effects on the purified cytochrome bd complex. We have 
found that antimycin A and UHDBT inhibit ubiquinol, 
but not TMPD, oxidation by the bd oxidase. Myxo- 
thiazol has no significant inhibitory effect with either 
substrate. The site of action of antimycin A has been 
localised to the low potential side of haem bsss and a 
branched electron transfer pathway appears to be in- 
volved in the oxidation of ubiquinol. 
2. Materials and methods 
The cytochrome bd-overproducing A. vinelandii strain, MK8, was 
grown essentially as previously described [5] with the modification of 
increased aeration. All steps were carried out at 4°C. Membrane vesi- 
cles [5] were first washed with 25 mM Tris-HCl, pH 8.0, containing 10 
mM EDTA and 0.5 M KCl, then suspended in 0.1 M potasium phos- 
phate buffer, pH 7.2, containing 2% (w/v) sodium cholate. After at least 
4 h stirring, the mixture was centrifuged at 45,000 x R for 20 min and 
the pellet again extracted twice with2% cholate in phosphate buffer. 
The final nellet was susnended in 0.1 M DhOSDhate buffer. DH 7.2. 
containing-l% (w/v) laur$ maltoside and, aiter 1-h stirring, o&ifuged 
at 45,000 x g for 15 min. Cytochrome bdwas purikd from the superna- 
tant by an ammonium sulphate cut between 50% and 80% saturation. 
The final preparation was suspended to a 6nal concentration of 10-l 5 
mg protein . ml-’ in 0.1 M potassium phosphate buffer, pH 7.2, and 
stored under liquid nitrogen. The pyridine haemochrome spectrum of 
the preparation showed the presence of haem b and haem d. No c-type 
haem was detected. 
Ubiquinone-1 was a gift from R. Cammack (King’s College London, 
UK) and was puritied before use by thin-layer chromatography on 
silica gel plates using chloroform : hexane :diethylether (10 : 10 : 1). Cy- 
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tochrome bd activity was assayed at room temperature using an oxygen 
electrode. A 2 : 1 (w/w) mixture of cytochrome bd complex and soybean 
phosphatidylcholme (Type IV-S; Sigma) was pre-incubated for 5 min 
in 0.1 M phosphate buffer, pH 7.9. The mixture was then injected into 
the oxygen electrode to an assay medium of 0.1 M phosphate buffer, 
pH 7.9, containing up to 150 PM ubiquinol-1 plus 1 mM D’IT (or 0.5 
mM TMPD plus 2 mM sodium ascorbate). Inhibitors were added from 
stock solutions in ethanol. Their concentrations were determined from 
optical spectra using the extinction coefficients given by von Jagow and 
Link [18]. The concentration of antimycin A used in the spectral exper- 
iments was raised to maintain an approximate antimycin/protein ratio 
as was used in the oxygen electrode xperiments. Optical spectra were 
recorded on a Varian Cary 210 spectrophotometer at room tempera- 
ture, using a spectral bandwidth of 1 nm and a scan rate of 2 nm . s-‘. 
Kinetic spectra were recorded using a Hewlett Packard 8452A diode- 
array spectrophotometer. All spectra were stored in digital form. 
3. Results and discussion 
DTT (1mM) 
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CIt can be seen from Fig. 1 that oxygen reduction by 
the purified cytochrome bd complex is inhibited by an- 
timycin A and UHDBT when ubiquinol-1 is used as the 
respiratory substrate. No inhibitory effect could be de- 
tected with myxothiazol. When the substrate TMPD 
(plus ascorbate) was used in place of ubiquinol-1 (plus 
DTT), none of the inhibitor compounds showed any 
inhibitory effect on the oxygen reduction rate (results not 
shown). Using ubiquinol-1 as the respiratory substrate, 
inhibition values were measured at various inhibitor con- 
centrations for different concentrations of substrate. 
Comish-Bowden and Dixon plots [ 191 for antimycin A 
inhibition were typical of a non-competitive interaction, 
with Ki = 4’ = 11 + 3 PM. Similar non-competitive 
inhibition was found for UHDBT with 4 = K’ = 20 f 5 
,uM. 
In the mitochondrial bc, complex, antimycin A bind- 
ing induces a spectral shift in both the a and y bands of 
the high potential reduced haem [18]. We have found a 
similar red shift in the Soret region around 430 nm on 
binding antimycin A to the reduced form of the purified 
bd complex of A. vinelundii (Fig. 2). Some perturbation 
around 560 nm also takes place. The spectral effects 
indicate that antimycin A binding affects one of the b- 
type haems, probably haem bSss. No spectral changes 
could be detected when UHBDT was added to the puri- 
fied complex. 
TMPD oxidation in the E. culi enzyme has been shown 
by Lorence et al. [7] to be unaffected by trypsin digestion 
of subunit I, a procedure that abolishes ubiquinol oxida- 
tion. Similarly, in the present experiments, TMPD oxida- 
tion is unaffected by antimycin A and UHDBT whilst 
ubiquinol oxidation is inhibited. The inhibitors therefore 
appear to be exerting their effect prior to the electron 
entry site of TMPD. We have further localised the site 
of inhibition by following spectral changes of the com- 
plex during reduction by ubiquinol-1 in the presence and 
absence of antimycin A. Spectra (with an integration 
time of 0.5 s) were taken every 10 s following the addition 
of ubiquinol-1 (plus DTT) to a solution of purified bd 
A 
\ myxothiaxol 
Fig. 1. Effect of antimycin A, UHBDT and myxothiaxol on oxygen 
reduction by cytochrome bd with ubiquinol-1 as substrate. The inhib- 
itors were added, in separate experiments, to a 1 ml suspension of 
cytochrome bd (9 pg protein/ml) in an oxygen electrode system as 
described in section 2. The separate traces are combined for the figure. 
complex under aerobic conditions. The digitalised spec- 
tra were analysed to extract absorbance changes with 
time at the wavelength pairs 560-578 mn, 595-604 run, 
628604 run and 604-650 mn (see Fig. 2). Changes at 
56&578 nm were used to monitor the redox state of both 
b-type haems. It is known for the E. coli bd complex that 
haem bsg5 has a strong p-band around 560 nm which 
overlaps the haem bsss a-band, with relative contribu- 
tions at 560 nm of approximately 50: 50 in the reduced 
minus air-oxidised spectrum [121. The extinction changes 
at 595-604 nm were used to monitor haem b595 alone. 
Ferrous haem d was monitored by changes in the 628 nm 
band (628-604 nm). The trough at 650 run is attributed 
to the oxygenated haem d [20] and the wavelength pair 
604-650 nm was used to monitor the changes in the haem 
d-oxy complex. 
It can be seen from Fig. 3 that the steady-state level 
of reduction of the b-type haems (560-578 run) during 
respiration with ubiquinol-1 as substrate is higher in the 
presence of antimycin A compared to its absence. This 
correlates with a slower respiration rate as measured by 
the increased time taken to anaerobiosis. When the sys- 
tem becomes anaerobic, the absorbance at 560 nm in- 
creases rapidly in the control sample, to around 85% of 
the final fully reduced spectrum (Fig. 3A). In the pres- 
ence of antimycin A, the amount of rapidly reduced 
b-type haem decreases. Full reduction only occurs after 
several minutes, at a much slower rate of around 0.002 
s-’ (Fig. 3B). At first sight, the simplest explanation 
might be that antimycin A is acting to block electron 
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Fig. 2. Perturbations in the spectrum of dithionite reduced cytochrome 
bd complex induced by the binding of antimycin A. Antimycin A was 
added to a final concentration of 350j~M to a suspension of cytochrome 
bd (1.7pM) in 0.1 M HEPES buffer, pH 7.0, plus 4 mM dithionite. The 
dotted line shows the antimycin/reduced minus reduced spectrum 
(Soret region enlarged by a factor of 5). Also shown, for comparison, 
is the dithionite reduced minus air-oxidised spectrum of the complex 
(solid line), with wavelength indicated for monitoring the spectral 
changes of the individual haems. See main text for details. 
flow between haems bSss and bsg5. Thus, when the system 
becomes anaerobic, b558 shows fast reduction by ubiqui- 
no1 but electron flow to bsg5 is much slower. However, 
further observations complicate this interpretation. The 
first is that the slow rate of reduction in the inhibited 
enzyme after anaerobiosis (0.002 s-r) is much less than 
the apparent electron flow rate through the same enzyme 
before the system goes anaerobic. This steady-state res- 
piration rate can be calculated from the time taken for 
the system to go anaerobic and is approximately 2 s-l, 
which agrees with separate xperiments using the oxygen 
electrode. If bsg5 was part of a linear electron transfer 
pathway from quinol to oxygen, then its rate of reduc- 
tion on anaerobiosis should match the rate of electron 
flow through the haem under steady-state (inhibited) 
conditions. This is clearly not the case. A more reasona- 
ble explanation for the tindings, suggested by the non- 
competitive form of the inhibition, is that antimycin A 
binding to a bd complex renders it kinetically inactive. 
The inhibited sample therefore would contain a mixture 
of fully active and fully inhibited enzyme, the proportion 
depending on the concentration of antimycin A. Some 
proportion of the fast phase of b haem reduction at 
anaerobiosis is then due to active enzyme molecules that 
have not bound antimycin A, and the slow phase is due 
to the reduction of inactive, antimycin A-inhibited en- 
zyme. A similar interpretation for the non-competitive 
inhibition of cytochrome oxidase by psychosine has been 
presented [21]. One prediction of this model is that in- 
creasing antimycin A concentrations hould decrease the 
proportion of the fast phase of reduction but not signif- 
icantly affect the rate of slow phase reduction. This is 
found to be the case, but it should be noted that the 
amount of fast phase never fell to below 50% at this 
wavelength (Fig. 4) despite the high inhibition of turn- 
over. It would appear that the reduction of one of the b 
haems is insensitive to antimycin A binding. The spectral 
changes at 595 mn show this to be haem bSg5. At all the 
levels of antimycin used, there was always a fast electron 
transfer to haem bsg5 when the system became anaerobic. 
We conclude that the slow spectral change at 560 nm in 
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Fig. 3. Effect of antimycin A on the rate and levels of reduction of haem 
bss8, haem b,,, and haem d in cytochrome bd, using ubiquinol-1 as 
respiratory substrate. Ubiquinol-1 (30 PM) plus D’lT (3 mM) was 
added to a solution of cytochrome bd (3 ph4) in 0.1 M potassium 
phosphate buffer, pH 7.9, and spectra taken every 10 s by a diode array 
spectrophotometer (scan time 0.1 s) over the wavelength range 400 to 
700 mn. Changes in absorbance with time were then calculated at the 
following wavelength pairs (see Fig. 2): (i) 56&578 nm; (ii) 604-650 mn; 
(iii) 628-604 mu; (iv) 595-604 nm. (A) Control, (B) plus antimycin A 
(328 PM). 
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the presence of antimycin A must be due to a slow reduc- 
tion of haem bss8. This was confumed by taking the 
difference spectrum of dithionite reduced minus 100 s 
after anaerobiosis. The resulting spectrum was typical of 
a b-type haem with features at 560 nm but none at 595 
nm. Similarly, antimycin A did not affect the rate of 
formation of ferrous haem d, monitored at 628 run. 
However, when the oxy-form of haem d was monitored 
at 650 mn in the presence of antimycin A, the maximum 
absorbance change did not occur until dithionite was 
added. It would appear that some oxy-form of haem d 
is trapped when the system becomes anaerobic and full 
reduction of the bound oxygen is inhibited. 
The lack of effect of antimycin A on the reduction of 
haem bsg5 and haem d whilst inhibiting the reduction of 
haem &, as well as the activity of the enzyme, strongly 
suggests a branched electron transfer pathway for the 
oxidation of ubiquinol. As pointed out recently by 
Musser et al. [17], the di&ulties of oxidizing a two 
electron donor by a one electron acceptor can be solved 
in a split electron transfer pathway. The present results 
provide experimental evidence for such a pathway in 
cytochrome bd (Fig. 5). We propose that under non- 
inhibited conditions, the two electron oxidation of ubiq- 
uinol involves two one-electron transfer reactions, one 
directly to haem b558 and the other to haem bsg5 (or haem 
d). Antimycin binding to the low potential side of haem 
bsss prevents electron transfer to one of the branches of 
dithionite 
m-f (1mM) 
Ql C’QW 
Fig. 4. Effect of antimycin A concentration on the absorbance changes 
of the b-type haems, monitored at X&578 mn, during the reduction 
of the cytochrome bd complex by ubiquinol-1 . Cytochrome bd (1.2 @l) 
was suspended at room temperature in potassium phosphate buffer (0.1 
M, pH 7.9) with ubiquinol-1 (90 PM) plus DTT (1 mM) in the absence 
(A) and presence (B-E) of antimycin A (B, 40 PM; C, 100 PM, D, 200 
pM; E, 300 PM). 
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Fig. 5. Proposed branched electron transfer pathway for the oxidation 
of ubiquinol by cytochrome bd. Ubiquinol oxidation involves direct 
reduction of both bSss and the haem b&haem d centre. Antimycin A 
binds at the low-potential side of haem b,,,, preventing reduction of b,,, 
but not bSg5 The interruption of the branched pathway by antimycin 
A can trap partially reduced oxygen intermediates on haem d. 
the pathway but not to haem bsg5 (and haem d). Activity 
is then inhibited by the inability of the semi-quinone to 
deliver further electrons to the oxygen reduction centre. 
Any intermediate forms of oxygen reduction will be 
trapped on haem d and only become reduced on the 
addition of dithionite. 
No inhibitory effect of myxothiazol could be detected 
on the bd oxidase but UHBDT was found to inhibit 
activity. Spectral experiments with UHBDT were com- 
plicated by the absorbance of the reduced form of the 
inhibitor but essentially similar results to those using 
antimycin A were observed on anaerobiosis. In cyto- 
chrome bq, the primary effect of UHBDT binding takes 
place at the iron-sulphur level, which is not present in 
cytochrome bd. However, UHBDT has also been shown 
to bind to the bc, complex, with lower affiity, at or near 
the same site as antimycin A [22]. This may be the case 
for cytochrome bd. It is unlikely that a branched electron 
transfer pathway for the oxidation of ubiquinol in the bd 
oxidase would be involved in any Q-loop mechanism 
since proton translocation by the bd oxidase (in E. co@) 
has not been detected [23]. However, it would be interest- 
ing to compare the effects of these inhibitors on the 
copper- containing quinol oxidases where putative Q- 
loop mechanisms have been considered [17. 
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